Previously, we described a reduction of oxidative phosphorylation in patients with thyroid cancer harboring the BRAF mutation [42], and we hypothesized that FGF21 was induced in the thyroid due to mitochondrial stress associated with thyroid tumorigenesis [43]. Here, BRAF is linked to thyroid cancer.